ChAdOx1-话题@MedSci - 梅斯（MedSci）

#ChAdOx1#

15篇内容 | 792人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1782947, encodeId=3c8c1e8294792, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=NEJM：ChAdOx1-S疫苗和BNT162b2疫苗接种后20周疫苗效果开始下降, objectType=article, longId=294148, objectId=c35629414864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c35629414864, replyNumber=0, likeNumber=116, createdTime=2022-04-21, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c35629414864, moduleTitle=NEJM：ChAdOx1-S疫苗和BNT162b2疫苗接种后20周疫苗效果开始下降, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c35629414864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782942, encodeId=23f91e829425a, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=NEJM：BNT162b2或ChAdOx1 nCoV-19疫苗对B.1.617（delta）变异株仍有效, objectType=article, longId=214648, objectId=97c0214648f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97c0214648f2, replyNumber=0, likeNumber=73, createdTime=2021-10-08, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97c0214648f2, moduleTitle=NEJM：BNT162b2或ChAdOx1 nCoV-19疫苗对B.1.617（delta）变异株仍有效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=97c0214648f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782941, encodeId=c50c1e82941cf, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=第二剂BNT162b2或ChAdOx1接种后棘突抗体减弱, objectType=article, longId=214411, objectId=9a6121441144, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a6121441144, replyNumber=0, likeNumber=90, createdTime=2022-01-30, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a6121441144, moduleTitle=第二剂BNT162b2或ChAdOx1接种后棘突抗体减弱, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9a6121441144)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782943, encodeId=aaa81e82943cd, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=Nat Med：异源ChAdOx1 nCoV-19/mRNA疫苗的免疫原性和反应原性 , objectType=article, longId=214903, objectId=0209214903db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0209214903db, replyNumber=0, likeNumber=81, createdTime=2021-10-11, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0209214903db, moduleTitle=Nat Med：异源ChAdOx1 nCoV-19/mRNA疫苗的免疫原性和反应原性 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0209214903db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782938, encodeId=55091e82938ff, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现特征免疫性血栓性血小板减少症, objectType=article, longId=211954, objectId=788621195419, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=788621195419, replyNumber=0, likeNumber=73, createdTime=2022-03-14, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788621195419, moduleTitle=JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现特征免疫性血栓性血小板减少症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=788621195419)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782937, encodeId=2bfb1e829375d, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=BMJ：丹麦和挪威的牛津-阿斯利康ChAdOx1-S疫苗接种后的动脉事件、静脉血栓栓塞、血小板减少和出血, objectType=article, longId=210915, objectId=00fa210915f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00fa210915f2, replyNumber=0, likeNumber=98, createdTime=2021-09-17, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00fa210915f2, moduleTitle=BMJ：丹麦和挪威的牛津-阿斯利康ChAdOx1-S疫苗接种后的动脉事件、静脉血栓栓塞、血小板减少和出血, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=00fa210915f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782946, encodeId=caae1e829466e, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=JNNP：ChAdOx1 nCov-19疫苗接种后脑静脉窦血栓形成的临床和生物学特征, objectType=article, longId=218361, objectId=839d21836137, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=839d21836137, replyNumber=0, likeNumber=85, createdTime=2022-06-27, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=839d21836137, moduleTitle=JNNP：ChAdOx1 nCov-19疫苗接种后脑静脉窦血栓形成的临床和生物学特征, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=839d21836137)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782944, encodeId=7f1d1e8294419, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=接种首剂ChAdOx1疫苗后一个月内脑静脉血栓风险较高, objectType=article, longId=215118, objectId=077d215118d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=077d215118d2, replyNumber=0, likeNumber=97, createdTime=2021-09-05, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=077d215118d2, moduleTitle=接种首剂ChAdOx1疫苗后一个月内脑静脉血栓风险较高, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=077d215118d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782939, encodeId=728d1e82939bb, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=NEJM：ChAdOx1 nCov-19接种后血栓性血小板减少事件研究, objectType=article, longId=212261, objectId=3d07212261b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d07212261b2, replyNumber=0, likeNumber=81, createdTime=2021-09-27, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d07212261b2, moduleTitle=NEJM：ChAdOx1 nCov-19接种后血栓性血小板减少事件研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3d07212261b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782945, encodeId=c57f1e8294519, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=Nat Commun：1期临床试验结果：单剂量ChAdOx1 Chik疫苗可诱导针对基孔肯雅病毒的中和抗体 , objectType=article, longId=215147, objectId=252621514ef3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=252621514ef3, replyNumber=0, likeNumber=78, createdTime=2022-07-12, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=252621514ef3, moduleTitle=Nat Commun：1期临床试验结果：单剂量ChAdOx1 Chik疫苗可诱导针对基孔肯雅病毒的中和抗体 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=252621514ef3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782936, encodeId=6ef51e829361f, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=Lancet：延长接种间隔至3个月或可发挥ChAdOx1nCoV-19疫苗很大的保护效果, objectType=article, longId=207526, objectId=29b220e526ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29b220e526ca, replyNumber=0, likeNumber=71, createdTime=2021-08-13, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29b220e526ca, moduleTitle=Lancet：延长接种间隔至3个月或可发挥ChAdOx1nCoV-19疫苗很大的保护效果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=29b220e526ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782940, encodeId=e9cb1e82940ca, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现的免疫性血栓性血小板减少症 , objectType=article, longId=212889, objectId=4f182128894d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f182128894d, replyNumber=0, likeNumber=116, createdTime=2022-04-01, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f182128894d, moduleTitle=JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现的免疫性血栓性血小板减少症 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4f182128894d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782934, encodeId=945b1e8293436, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=Pirbright研究所证明，两剂ChAdOx1 nCoV-19（AZD1222）疫苗可增强猪的免疫反应, objectType=article, longId=196432, objectId=51c11964320e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51c11964320e, replyNumber=0, likeNumber=82, createdTime=2020-06-30, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51c11964320e, moduleTitle=Pirbright研究所证明，两剂ChAdOx1 nCoV-19（AZD1222）疫苗可增强猪的免疫反应, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=51c11964320e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782935, encodeId=ef7b1e8293570, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=Lancet：ChAdOx1 nCoV-19疫苗安全性及预防症状性新冠肺炎效果显著, objectType=article, longId=204352, objectId=f58d20435296, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f58d20435296, replyNumber=0, likeNumber=86, createdTime=2021-10-13, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f58d20435296, moduleTitle=Lancet：ChAdOx1 nCoV-19疫苗安全性及预防症状性新冠肺炎效果显著, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f58d20435296)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1782933, encodeId=04b91e82933a2, content=<a href='/topic/show?id=b78845e0ba' target=_blank style='color:#2F92EE;'>#ChAdOx1#</a>, objectTitle=英国COVID-19候选疫苗ChAdOx1：将于下个月开始临床试验, objectType=article, longId=190564, objectId=50ab190564bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50ab190564bf, replyNumber=0, likeNumber=105, createdTime=2021-02-14, rootId=0, userName=anminleiryan, userId=e93e105, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50ab190564bf, moduleTitle=英国COVID-19候选疫苗ChAdOx1：将于下个月开始临床试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=50ab190564bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ChAdOx1

2020-05-29

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

NEJM：ChAdOx1-S疫苗和BNT162b2疫苗接种后20周疫苗效果开始下降

2022-04-21

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

NEJM：BNT162b2或ChAdOx1 nCoV-19疫苗对B.1.617（delta）变异株仍有效

2021-10-08

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

第二剂BNT162b2或ChAdOx1接种后棘突抗体减弱

2022-01-30

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

Nat Med：异源ChAdOx1 nCoV-19/mRNA疫苗的免疫原性和反应原性

2021-10-11

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现特征免疫性血栓性血小板减少症

2022-03-14

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

BMJ：丹麦和挪威的牛津-阿斯利康ChAdOx1-S疫苗接种后的动脉事件、静脉血栓栓塞、血小板减少和出血

2021-09-17

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

JNNP：ChAdOx1 nCov-19疫苗接种后脑静脉窦血栓形成的临床和生物学特征

2022-06-27

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

接种首剂ChAdOx1疫苗后一个月内脑静脉血栓风险较高

2021-09-05

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

NEJM：ChAdOx1 nCov-19接种后血栓性血小板减少事件研究

2021-09-27

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

Nat Commun：1期临床试验结果：单剂量ChAdOx1 Chik疫苗可诱导针对基孔肯雅病毒的中和抗体

2022-07-12

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

Lancet：延长接种间隔至3个月或可发挥ChAdOx1nCoV-19疫苗很大的保护效果

2021-08-13

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现的免疫性血栓性血小板减少症

2022-04-01

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

Pirbright研究所证明，两剂ChAdOx1 nCoV-19（AZD1222）疫苗可增强猪的免疫反应

2020-06-30

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

Lancet：ChAdOx1 nCoV-19疫苗安全性及预防症状性新冠肺炎效果显著

2021-10-13

anminleiryan (审核中...)

前往app查看评论内容

#ChAdOx1#

英国COVID-19候选疫苗ChAdOx1：将于下个月开始临床试验

2021-02-14

科室
- - 订阅+
  - 更多科室
工具
服务